Clinical Trial Update: Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

View source ↗

Summary

A completed non-interventional study comparing the effectiveness of Elocta with conventional factor VIII products in individuals with Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Elocta (efmoroctocog alfa)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophilia A | Status: COMPLETED